Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Timing of Adjuvant Radioactive Iodine Therapy Does Not Affect Overall Survival in Low- and Intermediate-Risk Papillary Thyroid Carcinoma.

Suman P, Wang CH, Moo-Young TA, Prinz RA, Winchester DJ. Timing of Adjuvant Radioactive Iodine Therapy Does Not Affect Overall Survival in Low- and Intermediate-Risk Papillary Thyroid Carcinoma. Am Surg. 2016 Sep; 82(9):807-14.

View in: PubMed